PubMed Health⌕ Search

Biomedical subjects

B McKee

Publications and source records attributed to B McKee.

12 recordsLinked to original sources
PubMed2002

Extremely low vertical-emittance beam in the accelerator test facility at KEK.

Electron beams with the lowest, normalized transverse emittance recorded so far were produced and confirmed in single-bunch-mode operation of the Accelerator Test Facility at KEK. We established a tuning method of the damping ring which achieves a small vertical dispersion and small x-y orbit coupling. The vertical emittance was less than 1% of the horizontal emittance. At the zero-intensity limit, the vertical normalized emittance was less than 2.8 x 10(-8) rad m at beam energy 1.3 GeV. At high intensity, strong effects of intrabeam scattering were observed, which had been expected in view of the extremely high particle density due to the small transverse emittance.

Journal Article↗
PubMed2000

The impact of polygraphy on admissions of victims and offenses in adult sexual offenders.

Sexual offenders are extremely reluctant to disclose their offending histories for a variety of psychosocial and legal reasons. The polygraph has shown promise as a intervention for eliciting admissions of past sexual offending behaviors. For 60 adult male sexual offender (35 inmates and 25 parolees), the number of victims and offenses were recorded from the Presentence Investigative Report, Sexual History Disclosure form, and 2 consecutive polygraph examination reports. Dramatic increases in the number of admitted victims and offenses were found for inmates, but not for parolees, across each source. However, there was a substantial decline in the number of victim and offense admissions by the second polygraph examination for both groups, even though 80% of the examination results reveled deception about sexual offending behaviors. Standardized use of sanctions and privileges for deceptive and nondeceptive polygraph results, respectively, are proposed as a way of eliciting full disclosure of offending histories for these offenders.

Adult↗
PubMed1995

Interprovincial data requirements for local health indicators: the British Columbia experience.

Indicators based on the registration of vital events are used to determine the health status of populations. The need for these indicators at the regional and community levels has grown with the trend toward decentralization in the delivery of health services. Such indicators are important because they affect funding and the types of service that are provided. Health status indicators tend to be associated with variables such as the level of urbanization or socioeconomic status. According to four indicators-mortality ratios for all causes of death, mortality ratios for external causes of death, infant mortality ratios, and low birth weight live birth ratios-some areas of British Columbia, specifically along the border with Alberta, have relatively good health, although the characteristics of these regions suggest that this should not be the case. However, a much different picture emerges when vital event data registered in Alberta for residents of these areas of British Columbia are considered. This article shows that for adequate health planning and program implementation, some communities need data from neighbouring provinces. It illustrates the effect of incorporating Alberta data into the development of health status indicators for British Columbia. It also suggests that similar adjustments may be necessary for data compiled in other provinces.

Adolescent↗
PubMed1990

Multicenter evaluation of the hemodynamic effects of bisoprolol in patients with mild to moderate hypertension.

Twenty-six patients with mild-to-moderate essential hypertension participated in a 6-week outpatient, multicenter, randomized, double-blind, placebo-controlled two-way crossover study to assess the hemodynamic effects of bisoprolol (20 mg QD) at steady state. Hemodynamic assessments included sitting blood pressure, heart rate, and left-ventricular ejection fraction by radionuclide ventriculography after 7 days of bisoprolol or placebo at trough (24 h post-dose) and peak (3 h post-dose) values. The group adjusted mean ejection fraction was not significantly different in patients receiving bisoprolol compared with the placebo group at either peak or trough measurements; in fact, means in patients taking bisoprolol were slightly higher than in the placebo group. No symptomatic hypotension was documented. Blood pressure, measured 24 hours after dosing, was significantly lower in those receiving bisoprolol when compared with the placebo group, by 7.7 mm Hg and 9 mm Hg for diastolic and systolic blood pressure, respectively. Similarly, mean values of heart rate were 10 beats/min lower in the bisoprolol patients than in the placebo group. Only headache and insomnia occurred as adverse events. Bisoprolol (20 mg QD) effectively lowered blood pressure over a 24-hour period without significantly reducing ejection fraction or causing adverse clinical or biochemical events.

Adrenergic beta-Antagonists↗